Hemoglobin-based Oxygen Carriers (HBOC)-What the next generation holds: When red blood cells are not an option

Shock

Volumn 52, Issue 1S, 2019, Pages 4-6

  Hill Pryor, Crystal ^a   Pusateri, Anthony E ^b   Weiskopf, Richard B ^c  

^a U S ARMY MEDICAL RESEARCH AND MATERIEL COMMAND   (United States)

^b U S ARMY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; HEMOGLOBIN BASED OXYGEN CARRIER; OXYGEN; UNCLASSIFIED DRUG; BLOOD SUBSTITUTE;

DISEASE ASSOCIATION; EDITORIAL; ERYTHROCYTE; ERYTHROCYTE CONCENTRATE; HEALTH CARE QUALITY; HUMAN; INCIDENCE; MASS DISASTER; OXYGEN TRANSPORT; RISK FACTOR; ANIMAL; BLOOD; CYTOLOGY; METABOLISM;

ANIMALS; BLOOD SUBSTITUTES; ERYTHROCYTES; HEMOGLOBINS; HUMANS; OXYGEN;

EID: 85072105812     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0000000000001421     Document Type: Editorial

References (38)

1. Cap AP. Unmet Military Need: When RBCs Are Not an Option In: Summary of the Interagency Oxygen Carrier State of the Science Meeting. February 2017. US Army Medical Research and Materiel Command, Fort Detrick Maryland. Pages 2-4. Available at: Https://ccc.amedd.army.mil/Portfolios/Pages/Oxygen-Carrier-Meeting-2017.aspx. Accessed August 8, 2019.
2. Eastridge BJ, Mabry RL, Seguin P, Cantrell J, Tops T, Uribe P, Uribe P, Mallett O, Zubko T, Oetjen-Gerdes L, et al.: Death on the battlefield (2001-2011): Implications for the future of combat casualty care. J Trauma Acute Care Surg 73(6 suppl 5):S431-S437, 2012.
3. Jenkins D. Unmet Civilian Medical Need: When RBCs Are Not an Option. In: Summary of the Interagency Oxygen Carrier State of the Science Meeting. February 2017. US Army Medical Research and Materiel Command, Fort Detrick Maryland. Pages 4-6. Available at: Https://ccc.amedd.army.mil/Portfolios/Pages/Oxygen-Carrier-Meeting-2017.aspx. Accessed August 8, 2019.
4. Hrdina C. Potential Use of HBOCs in Mass Casualties In: Summary of the Interagency Oxygen Carrier State of the Science Meeting. February 2017. US Army Medical Research and Materiel Command, Fort Detrick Maryland. Pages 6-7. Available at: Https://ccc.amedd.army.mil/Portfolios/Pages/Oxygen-Carrier-Meeting-2017.aspx. Accessed August 8, 2019.
5. de Vries Y, Matton APM, Nijsten MWN, Werner MJM, van den Berg AP, de Boer MT, Buis CI, Fujiyoshi M, de Kleine RHJ, van Leeuwen OB, et al.: Pretransplant sequential hypo-A nd normothermic machine perfusion of suboptimal livers donated after circulatory death using a hemoglobin-based oxygen carrier perfusion solution. Am J Transplant 19:1202-1211, 2019.
6. O'Brien SF, Yi QL, Fan W, Scalia V, Fearon MA, Allain JP: Current incidence and residual risk of HIV, HBVand HCVat Canadian Blood Services. Vox Sang 103(1):83-86, 2012.
7. Allain JP, Owusu-Ofori AK, Assennato SM, Marschner S, Goodrich RP, Owusu-Ofori S: Effect of Plasmodium inactivation in whole blood on the incidence of blood transfusion-transmitted malaria in endemic regions: The African Investigation of the Mirasol System (AIMS) randomized controlled trial. Lancet 387(10029):1753-1761, 2016.
8. Alayash AI: Mechanisms of toxicity and modulation of hemoglobin-based oxygen carriers. Shock 52(Suppl. 1):41-49, 2019.
9. Mollan TL, Alayash AI: Redox reactions of hemoglobin: Mechanisms of toxicity and control. Antioxid Redox Signal 18(17):2251-2253, 2013.
10. Benitez Cardenas AS, Samuel PP, Olson JS: Current challenges in the development of acellular hemoglobin oxygen carriers by protein engineering. Shock 52(Suppl. 1):28-40, 2019.
11. Gupta AS: Hemoglobin-based oxygen carriers: Current state-of-the-art and novel molecules. Shock 52(Suppl. 1):70-83, 2019.
12. Toy P, Gajic O, Bacchetti P, Looney MR, Gropper MA, Hubmayr R, Lowell CA, Norris PJ, Murphy EL, Weiskopf RB, et al.: Transfusion-related acute lung injury: Incidence and risk factors. Blood 119(7):1757-1767, 2012.
13. Bilgin YM, Brand A: Transfusion-related immunomodulation: A second hit in an inflammatory cascade Vox Sang 95(4):261-271, 2008.
14. Ibanez B. Addressing Clinical Issues and Use: HBOCs Cardiovascular. In: Summary of the Interagency Oxygen Carrier State of the Science Meeting. February 2017. US Army Medical Research and Materiel Command, Fort Detrick Maryland. Pages 42-43. Available at: Https://ccc.amedd.army. mil/Portfolios/Pages/Oxygen-Carrier-Meeting-2017.aspx. Accessed August 8, 2019.
15. Meliga E, Vranckx P, Regar E, Kint PP, Duncker DJ, Serruys PW: Proof-ofconcept trial to evaluate haemoglobin based oxygen therapeutics in elective percutaneous coronary revascularisation. Rationale, protocol design and haemodynamic results. EuroIntervention 4(1):99-107, 2008.
16. Serruys PW, Vranckx P, Slagboom T, Regar E, Meliga E, de Winter RJ, Heyndrickx G, Schuler G, van Remortel EA, Dube GP, et al.: Haemodynamic effects, safety, and tolerability of haemoglobin-based oxygen carrier-201 in patients undergoing PCI for CAD. EuroIntervention 3(5):600-609, 2008.
17. Burhop K. Overview of Baxter's Hemoglobin Therapeutics (Trauma) Program. In: Summary of the Interagency Oxygen Carrier State of the Science Meeting. February 2017. US Army Medical Research and Materiel Command, Fort Detrick Maryland. Pages 22-23. Available at: Https://ccc.amedd.army. mil/Portfolios/Pages/Oxygen-Carrier-Meeting-2017.aspx. Accessed August 8, 2019.
18. Gould S. HBOC Clinical Trials: Lessons Learned. In: Summary of the Interagency Oxygen Carrier State of the Science Meeting. February 2017. US Army Medical Research and Materiel Command, Fort Detrick Maryland. Pages 23-25. Available at: Https://ccc.amedd.army.mil/Portfolios/Pages/Oxygen-Carrier-Meeting-2017.aspx. Accessed August 8, 2019.
19. Greenburg AG. HBOC Clinical Trials: Lessons Learned from the Hemosol Trial in Cardiac Surgery. In: Summary of the Interagency Oxygen Carrier State of the Science Meeting. February 2017. US Army Medical Research and Materiel Command, Fort Detrick Maryland. Pages 29-31. Available at: Https://ccc. amedd.army.mil/Portfolios/Pages/Oxygen-Carrier-Meeting-2017.aspx. Accessed August 8, 2019.
20. Keipert P. Sangart's MP4OX development in trauma: Lessons learned. In: Summary of the Interagency Oxygen Carrier State of the Science Meeting. February 2017. US Army Medical Research and Materiel Command, Fort Detrick Maryland. Pages 27-29. Available at: Https://ccc.amedd.army. mil/Portfolios/Pages/Oxygen-Carrier-Meeting-2017.aspx. Accessed August 8, 2019.
21. Mackenzie CF, Dube GP, Pitman A, Zafirelis M: Users Guide to Pitfalls and Lessons Learned about HBOC-201 during Clinical Trials, Expanded Access and Clinical Use in 1, 701 Patients. Shock 52(Suppl. 1):92-99, 2019.
22. Moore EE, Moore FA, Fabian TC, Bernard AC, Fulda GJ, Hoyt DB, Duane TM, Weireter LJ Jr, Gomez GA, Cipolle MD, et al.: Human polymerized hemoglobin for the treatment of hemorrhagic shock when blood is unavailable: The USA multicenter trial. J Am Coll Surg 208(1):1-13, 2009.
23. Levien LJ: South Africa: Clinical experience with Hemopure. ISBT Sci Series 1:167-173, 2006.
24. Mer M, Hodgson E, Wallis L, Jacobson B, Levien L, Snyman J, Sussman JM, James M, van Gelder A, Allgaier R, et al.: Hemoglobin glutamer-250 (bovine) in South Africa: Consensus usage guidelines from clinician experts who have treated patients. Transfusion 56(10):2631-2636, 2016.
25. Levien L. Hemopure in South Africa: Some clinical observations. In: Summary of the Interagency Oxygen Carrier State of the Science Meeting. February 2017. US Army Medical Research and Materiel Command, Fort Detrick Maryland. Pages 43-44. Available at: Https://ccc.amedd.army.mil/Portfolios/Pages/Oxygen-Carrier-Meeting-2017.aspx. Accessed August 8, 2019.
26. Mackenzie CF, Moon-Massat PF, Shander A, Javidroozi A, Greenburg G:When blood is not an option: Factors affecting survival after use of a hemoglobin-based oxygen carrier in 54 patients with life-threatening anemia. Anesth Analg 110:685-693, 2010.
27. Weiskopf RB, Beliaev AM, Shander A, Guinn NR, Cap AP, Ness PM, Silverman TA: Silverman: Addressing the unmet need of life-threatening anemia with hemoglobin-based oxygen carriers. Transfusion 57(1):207-214, 2017.
28. Carson JL, Noveck H, Berlin JA, Gould SA: Mortality and morbidity in patients with very low postoperative Hb levels who decline blood transfusion. Transfusion 42(7):812-818, 2002.
29. Shander A, Javidroozi M, Naqvi S, Aregbeyen O, Caylan M, Demir S, Juhl A: An update on mortality and morbidity in patients with very low postoperative hemoglobin levels who decline blood transfusion (CME). Transfusion 54(10 pt 2):2688-2695, 2014.
30. Beliaev AM, Marshall RJ, Gordon M, Smith W, Windsor JA: Clinical benefits and cost-effectiveness of allogeneic red-blood-cell transfusion in severe symptomatic anaemia. Vox Sang 103(1):18-24, 2012.
31. Guinn NR, Cooter ML, Villalpando C, Weiskopf RB: Severe anemia associated with increased risk of death and myocardial ischemia in patients declining blood transfusion. Transfusion 58(10):2290-2296, 2018.
32. Weiskopf RB. Addressing unmet needs with HBOCs when rbcs are not an option. In: Summary of the Interagency Oxygen Carrier State of the Science Meeting. February 2017. US Army Medical Research and Materiel Command, Fort Detrick Maryland. Pages 45-48. Available at: Https://ccc.amedd.army.mil/Portfolios/Pages/Oxygen-Carrier-Meeting-2017.aspx. Accessed August 8, 2019.
33. Abuchowski A: SANGUINATE (PEGylated Carboxyhemoglobin Bovine): Mechanism of action and clinical update. Artif Organs 41(4):346-350, 2017.
34. Abuchowski A. Sanguinate for the treatment of sickle cell disease. In: Summary of the Interagency Oxygen Carrier State of the Science Meeting. February 2017. US Army Medical Research and Materiel Command, Fort Detrick Maryland. Pages 49-51. Available at: Https://ccc.amedd.army.mil/Portfolios/Pages/Oxygen-Carrier-Meeting-2017.aspx. Accessed August 8, 2019.
35. Moon-Massat PF. Statue of HBOCs for TBI indication. In: Summary of the Interagency Oxygen Carrier State of the Science Meeting. February 2017. US Army Medical Research and Materiel Command, Fort Detrick Maryland. Pages 40-42. Available at: Https://ccc.amedd.army.mil/Portfolios/Pages/Oxygen-Carrier-Meeting-2017.aspx. Accessed August 8, 2019.
36. Porte RJ. Donor organ machine perfusion-application of an hemoglobin-based oxygen carrier. In: Summary of the Interagency Oxygen Carrier State of the Science Meeting. February 2017. US Army Medical Research and Materiel Command, Fort Detrick Maryland. Pages 31-34. Available at: Https://ccc. amedd.army.mil/Portfolios/Pages/Oxygen-Carrier-Meeting-2017.aspx. Accessed August 8, 2019.
37. Matton A, Burlage L, van Rijn R, Karangwa Y, de Vries Y, op den Dries S, Sutton M, Westerkamp A, Lisman T, Porte R: Normothermic machine perfusion of donor livers using a novel hemoglobin based oxygen carrier solution, eliminating the need for human blood products. HPB 18(S1):e73, 2016.
38. Vrselja Z, Daniele SG, Silbereis J, Talpo F, Morozov YM, Sousa AMM, Tanaka BS, Skarica M, Pletikos M, Kaur N, et al.: Restoration of brain circulation and cellular functions hours post-mortem. Nature 568:336-343, 2019.